Report cover image

InVitae Corp (NVTAQ) - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 08, 2024
Length 33 Pages
SKU # GBDT18719615

Description

Summary


Invitae Corp (Invitae) is a medical genetics company that provides testing, health data and digital health solutions for various genetic disorders. The company provides genetic testing services in multiple clinical areas that include hereditary cancer, women's health, precision oncology, pharmacogenomics and rare diseases. It uses process automation, proprietary design, robotics and bioinformatics software solutions to support genetic counseling, variant interpretation, and clinical trial matching. The company serves payers, healthcare providers, biopharma partners and patient advocacy groups. It operates in Australia, India, Japan, Singapore, Belgium, Germany, Latvia, the Netherlands, the US, Israel and Brazil. Invitae is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InVitae Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

33 Pages
InVitae Corp Company Overview
InVitae Corp Company Snapshot
InVitae Corp Pipeline Products and Ongoing Clinical Trials Overview
InVitae Corp – Pipeline Analysis Overview
InVitae Corp - Key Facts
InVitae Corp - Major Products and Services
InVitae Corp Pipeline Products by Development Stage
InVitae Corp Pipeline Products Overview
Comprehensive Cancer Array Test
Comprehensive Cancer Array Test Product Overview
Diagnostic Test - Pre-Pregnancy
Diagnostic Test - Pre-Pregnancy Product Overview
Expanded Carrier Screening Test
Expanded Carrier Screening Test Product Overview
Genomic Panel
Genomic Panel Product Overview
Molecular Assay - Age-Related Macular Degeneration
Molecular Assay - Age-Related Macular Degeneration Product Overview
NTRK CDx
NTRK CDx Product Overview
Personalized Cancer Monitoring Laboratory Developed Test
Personalized Cancer Monitoring Laboratory Developed Test Product Overview
Therapy selection LDT
Therapy selection LDT Product Overview
InVitae Corp - Key Competitors
InVitae Corp - Key Employees
InVitae Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InVitae Corp, Recent Developments
Mar 05, 2024: Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting
Nov 06, 2023: Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships
Oct 25, 2023: Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results
Oct 19, 2023: Invitae Appoints Dr. David Sholehvar as Chief Operating Officer
Oct 16, 2023: InVitae Receives DeNovo Clearance for Invitae Common Hereditary Cancers Panel
Oct 12, 2023: Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer
Sep 29, 2023: FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types
Sep 25, 2023: Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO
Aug 28, 2023: Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer
Aug 15, 2023: Clinical Trial Results Support Genetic Testing Of All Patients With Prostate Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: InVitae Corp Pipeline Products and Ongoing Clinical Trials Overview
Table 2: InVitae Corp Pipeline Products by Equipment Type
Table 3: InVitae Corp Pipeline Products by Indication
Table 4: InVitae Corp, Key Facts
Table 5: InVitae Corp, Major Products and Services
Table 6: InVitae Corp Number of Pipeline Products by Development Stage
Table 7: InVitae Corp Pipeline Products Summary by Development Stage
Table 8: Comprehensive Cancer Array Test - Product Status
Table 9: Comprehensive Cancer Array Test - Product Description
Table 10: Diagnostic Test - Pre-Pregnancy - Product Status
Table 11: Diagnostic Test - Pre-Pregnancy - Product Description
Table 12: Expanded Carrier Screening Test - Product Status
Table 13: Expanded Carrier Screening Test - Product Description
Table 14: Genomic Panel - Product Status
Table 15: Genomic Panel - Product Description
Table 16: Molecular Assay - Age-Related Macular Degeneration - Product Status
Table 17: Molecular Assay - Age-Related Macular Degeneration - Product Description
Table 18: NTRK CDx - Product Status
Table 19: NTRK CDx - Product Description
Table 20: Personalized Cancer Monitoring Laboratory Developed Test - Product Status
Table 21: Personalized Cancer Monitoring Laboratory Developed Test - Product Description
Table 22: Therapy selection LDT - Product Status
Table 23: Therapy selection LDT - Product Description
Table 24: InVitae Corp, Key Employees
Table 25: InVitae Corp, Subsidiaries
Table 26: Glossary
List of Figures
Figure 1: InVitae Corp Pipeline Products by Equipment Type
Figure 2: InVitae Corp Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us